Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Progenitor Cell Mobilisation

Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders

Abstract

We have explored the efficacy of salvage chemotherapy combination, IAPVP-16 (ifosfamide 5 g/m2 on day 1; VP-16 100 mg/m2 on days 1–3; ara-C 1.2 g/m2/12 h on days 1 and 2; methylprednisolone 80 mg/m2 on days 1–5) plus g-csf for pbpc mobilization. this protocol was used in 45 patients with relapsed or refractory lymphoproliferative diseases who underwent 85 leukaphereses. in 41 patients >2 × 106/kg CD34+ cells were obtained after a median of two procedures. The median number of CD34+ cells harvested was 3.2 × 106/kg per apheresis and 8.4 × 106/kg per patient. Seven of 10 patients who had failed previous mobilization attempts achieved more than 2 × 106 CD34+ cells/kg in a maximum of three aphereses. A history of previous mobilization failure and a low platelet count (<150 × 109/l) negatively influenced the CD34+ cell yield in univariate and multivariate analyses. A good correlation was found between the circulating CD34+cells/μl and the CD34+ cells and CFU-GM in the leukaphereses products (r = 0.93 and r = 0.73, P < 0.001), and 17 cd34+cells/μl predicted the achievement of >2 × 106/kg CD34+ cells in a single leukapheresis in more than 90% of cases. IAPVP-16 plus G-CSF may be specially indicated in tandem transplantations or CD34+ selection and in patients who have failed previous mobilization attempts. Bone Marrow Transplantation (2000) 26, 127–132.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Gratwohl A, Hermans J, Baldomero H . Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Bone Marrow Transplantation (EBMT) Bone Marrow Transplant 1997 19: 407–419

    Article  CAS  Google Scholar 

  2. To LB, Roberts MM, Haylock DN et al. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants Bone Marrow Transplant 1992 9: 227–284

    Google Scholar 

  3. Russell NH, McQuaker G, Stainer C et al. Stem cell mobilisation in lymphoproliferative diseases Bone Marrow Transplant 1998 22: 935–940

    Article  CAS  Google Scholar 

  4. Bensinger WI, Longin K, Appelbaum F et al. PB stem cells (PBSCs) collected after recombinant granulocyte colony-stimulating factor (rh G-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation Br J Haematol 1994 87: 825–831

    Article  CAS  Google Scholar 

  5. To LB, Haylock D, Simmons PJ, Juttner C . The biology and clinical uses of blood stem cells Blood 1997 89: 2233–2258

    CAS  PubMed  Google Scholar 

  6. Lopez R, Martino R, Sureda A et al. Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience Haematologica 1999 84: 350–355

    CAS  PubMed  Google Scholar 

  7. Garcia J, Martinez E . La criopreservación de precursores hematopoyéticos: su papel en Hematología y Oncología Biol Clin Hematol 1983 5: 99–107

    Google Scholar 

  8. Pike BL, Robinson WA . Human bone marrow colony growth in agar gel J Cell Physiol 1970 76: 77–84

    Article  CAS  Google Scholar 

  9. Martinez C, Mateu R, Sureda A et al. Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma Transplant Proc 1995 27: 2355–2356

    CAS  PubMed  Google Scholar 

  10. Martinez C, Sureda A, Martino R et al. Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 μg/m2) after salvage chemotherapy for lymphoma Bone Marrow Transplant 1997 20: 855–858

    Article  CAS  Google Scholar 

  11. Lopez R, Martino R, Brunet S et al. Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas Haematologica 1999 84: 911–916

    CAS  PubMed  Google Scholar 

  12. Bender J, To LB, Williams S, Schwartzberg L . Defining a therapeutic dose of peripheral blood stem cells J Hematother 1992 1: 329–334

    Article  CAS  Google Scholar 

  13. Haynes AP, Hunter A, McQuaker G et al. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF Bone Marrow Transplant 1995 16: 359–363

    CAS  PubMed  Google Scholar 

  14. Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma J Clin Oncol 1999 17: 3776–3785

    Article  CAS  Google Scholar 

  15. Rosenfeld CS, Shadduck RK, Zeigler ZR et al. Cyclophosphamide-mobilized peripheral blood stem cell in patients with lymphoid malignancies Bone Marrow Transplant 1995 15: 433–438

    CAS  PubMed  Google Scholar 

  16. Haas R, Möhle R, Frühauf S et al. Patients characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma Blood 1994 83: 3787–3794

    CAS  PubMed  Google Scholar 

  17. Olivieri A, Offidani M, Ciniero L et al. Optimization of the yield of PBSC for autotransplantation mobilized by high dose chemotherapy and G-CSF: proposal for a mathematical model Bone Marrow Transplant 1994 14: 273–278

    CAS  PubMed  Google Scholar 

  18. Koumakis G, Vassilomanolakis M, Hatzichristou H et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single leukapheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies Bone Marrow Transplant 1996 18: 1065–1072

    CAS  PubMed  Google Scholar 

  19. McQuaker IG, Haynes AP, Stainer C et al. Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide Br J Haematol 1997 98: 228–233

    Article  CAS  Google Scholar 

  20. Weaver CH, Schwartzberg LS, Birch R et al. Collection of peripheral blood progenitor cells after the administration of cyclophosphamide, etoposide, and granulocyte-colony-stimulating factor: an analysis of 497 patients Transfusion 1997 37: 896–903

    Article  CAS  Google Scholar 

  21. Watts MJ, Sullivan AM, Jamieson E et al. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphoma J Clin Oncol 1997 15: 535–546

    Article  CAS  Google Scholar 

  22. Armitage S, Hargreaves R, Samson D et al. CD34 counts to predict the adequate collection of peripheral blood progenitor cells Bone Marrow Transplant 1997 20: 587–591

    Article  CAS  Google Scholar 

  23. Engelhardt M, Winkler J, Waller C et al. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF Bone Marrow Transplant 1997 19: 529–537

    Article  CAS  Google Scholar 

  24. Díaz MA, Garcia-Sanchez F, Lillo R et al. Large-volume leukapheresis in pediatric patients: pre-apheresis peripheral blood CD34+ cell count predicts progenitor cell yield Haematologica 1999 84: 32–35

    PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported in part by grant FIS 97/0626 from the Fondo de Investigaciones Sanitarias del Ministerio de Sanidad y Consumo and a grant from Fundación Ramón Areces (JS/1997–1999).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altés, A., López, R., Martino, R. et al. Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders. Bone Marrow Transplant 26, 127–132 (2000). https://doi.org/10.1038/sj.bmt.1702476

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702476

Keywords

This article is cited by

Search

Quick links